Lindy Biosciences is a development-stage protein therapeutic formulations company.
Lindy Biosciences has raised $3.2M in total funding. The most recent round was Series B. The last funding was announced in March 2022.
Lindy Biosciences's investors include Good Growth Capital, IAG Capital Partners, North Carolina Biotechnology Center, Next Act Fund, alumshares.
Lindy Biosciences is headquartered in Morrisville, United States.
Lindy Biosciences is a development-stage protein therapeutic formulations company.
Lindy Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lindy Biosciences — Funding & Investors." VCBacked, March 29, 2022, https://www.vcbacked.co/company/lindy-biosciences. Accessed August 13, 2026.
VCBacked. (2022). Lindy Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/lindy-biosciences
{{cite web |title=Lindy Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/lindy-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated